Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1617
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17962515 | PROCESS FOR ALTERING THE COLOR OF KERATIN FIBERS | Final Rejection | L'Oreal |
| 18902135 | POLYMER NANOPARTICLE COMPOSITIONS FOR NON-VIRAL GENE DELIVERY TO THE CENTRAL NERVOUS SYSTEM | Non-Final OA | BATTELLE MEMORIAL INSTITUTE |
| 17949484 | CURABLE COMPOUNDS AND FORMULATIONS FOR BIOMEDICAL APPLICATIONS | Non-Final OA | 3D SYSTEMS, INC. |
| 17423400 | COMBINATION REMEDY | Final Rejection | SYMRISE AG |
| 18704916 | USE OF MILK EXOSOME IN PREPARATION OF DRUG CARRIER | Non-Final OA | Panexo Biotech SG PTE. LTD |
| 18424973 | SURFACE TREATMENT OF CONTACT LENS AND TREATMENT OF OCULAR DISCOMFORT BY WATER SOLUBLE POLYMERS AND LIPIDS/LIPOSOMES | Non-Final OA | Yeda Research and Development Co. Ltd. |
| 17753795 | STICKER FORMULATION CONTAINING A SULFOPOLYMER | Non-Final OA | Eastman Chemical Company |
| 17926847 | ANTIVIRAL POLYMERS | Non-Final OA | The University of Manchester |
| 18579943 | Compositions and Methods For Reducing Immune Intolerance and Treating Autoimmune Disorders | Non-Final OA | Lapix Therapeutics, Inc. |
| 18491871 | MODIFIED RELEASE FORMULATIONS OF PRIDOPIDINE | Non-Final OA | Prilenia Neurotherapeutics Ltd. |
| 17006705 | MEDICAL DEVICES CONTAINING POLY(BUTYLENE SUCCINATE) AND COPOLYMERS THEREOF | Non-Final OA | Tepha, Inc. |
| 17601325 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE AZOLATED LOCAL ANTIFUNGAL SUBSTANCE | Non-Final OA | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC, |
| 17635815 | DRUG-POLYMER AMORPHOUS SOLID DISPERSIONS USING LINEAR POLY(ACRYLIC ACID) POLYMERS | Final Rejection | LUBRIZOL ADVANCED MATERIALS, INC. |
| 16857458 | INTRACANALICULAR HYDROGEL INSERTS FOR THE DELIVERY OF ANESTHETICS | Final Rejection | Ocular Therapeutix, Inc. |
| 16069826 | DEVICES AND COMPOSITIONS AND METHODS OF USE THEREOF | Final Rejection | RevBio, Inc. |
| 18050615 | ELECTROSPUN FIBERS HAVING A PHARMACEUTICAL AND METHODS OF MAKING AND USING THE SAME | Non-Final OA | NFS IP Holdings, LLC |
| 17718575 | FIBER SCAFFOLDS FOR USE CREATING IMPLANTABLE STRUCTURES | Non-Final OA | NFS IP Holdings, LLC |
| 17796453 | PHOTOSYNTHESIS STIMULATOR BASED ON HYBRID CARBON NANOPARTICLES, RELATED PRODUCTION METHOD AND RELATED USE AS NANOBIOSTIMULANTS AND NANOFERTILIZERS IN AGRICULTURAL CROPS | Non-Final OA | EMPRESA BRASILEIRA DE PESQUISA AGROPECUARIA - EMBRAPA |
| 17870440 | TREATED NON-HYDRATED SUPER ABSORBENT POLYMERS | Non-Final OA | DRYJECT INC. ACQUISITION CORPORATION |
| 17630404 | AGRICULTURAL FORMULATION | Final Rejection | ISHIHARA SANGYO KAISHA, LTD. |
| 17828904 | KITS, COMPOSITIONS AND METHODS FOR WOUND TREATMENT AND MANAGEMENT | Non-Final OA | DIRECT COMPONENTS, INC. |
| 17742847 | OCULAR DEVICE DELIVERY METHODS AND SYSTEMS | Final Rejection | LayerBio, Inc. |
| 17604587 | PROCESS FOR CROSSLINKING A POLYMER | Non-Final OA | LABORATOIRES VIVACY |
| 17125180 | METHODS FOR TREATING EYE DISORDERS USING OCULAR IMPLANTS | Final Rejection | Retina Foundation Of The Southwest |
| 17538714 | MULTIFUNCTIONAL MICROCARRIERS WITH THERMO-RESPONSIVE BIOMATERIAL COATING AND USE THEREOF | Final Rejection | UVic Industry Partnerships Inc. |
| 17754150 | HYDROGEL BASED ON ZINC GLUCONATE AND HYALURONIC ACID ESTERS | Non-Final OA | BMG PHARMA S.P.A. |
| 17543773 | Non-Uniformly Stiff Polymeric Scaffolds and Methods for Producing Thereof | Non-Final OA | Regenosca SA |
| 17604439 | Pharmaceutical Inhalation Aerosol and Preparation Method Therefor | Final Rejection | CF PharmTech, Inc. |
| 17432430 | WATER-SOLUBLE NAPHTHOQUINONE DERIVATIVE COMPOSITION AND METHOD FOR PRODUCING SAME, WATER-SOLUBLE COMPOSITION FOR CONTROLLING HARMFUL ALGAE, METHOD FOR CONTROLLING LARGE-SCALE HARMFUL ALGAE, AND AUTOMATION SYSTEM FOR AI-MONITORING, REMOVING, AND PREVENTING LARGE-SCALE HARMFUL ALGAE | Final Rejection | WATER-BIOTECH |
| 17137985 | BACILLUS AMYLOLIQUEFACIENS AND NEONICOTINOIDS MIXTURES AND METHODS OF USE THEREOF | Final Rejection | Valent U.S.A. LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy